[go: up one dir, main page]

MX2007010099A - Las 1,3-tiazol-5-carboxamidas utiles como agentes quimioterapeuticos contra el cancer. - Google Patents

Las 1,3-tiazol-5-carboxamidas utiles como agentes quimioterapeuticos contra el cancer.

Info

Publication number
MX2007010099A
MX2007010099A MX2007010099A MX2007010099A MX2007010099A MX 2007010099 A MX2007010099 A MX 2007010099A MX 2007010099 A MX2007010099 A MX 2007010099A MX 2007010099 A MX2007010099 A MX 2007010099A MX 2007010099 A MX2007010099 A MX 2007010099A
Authority
MX
Mexico
Prior art keywords
thiazole
chemotherapeutic agents
cancer chemotherapeutic
carboxamides useful
carboxamides
Prior art date
Application number
MX2007010099A
Other languages
English (en)
Inventor
Harold C E Kluender
Julie A Dixon
Philip Wickens
Zhenqiu Hong
Catherine Brennan
Chih-Yuan Chuang
Charles Kreiman
Ellalahewage Kumarasinghe
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of MX2007010099A publication Critical patent/MX2007010099A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invencion esta relaciona con los nuevos compuestos de la 1,3-tiazol-5-carboxamida, las composiciones farmaceuticas que contienen tales componentes, y el uso de dichos compuestos o composiciones como agentes quimioterapicos contra el cancer.
MX2007010099A 2005-03-04 2006-02-24 Las 1,3-tiazol-5-carboxamidas utiles como agentes quimioterapeuticos contra el cancer. MX2007010099A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65898505P 2005-03-04 2005-03-04
PCT/US2006/006436 WO2006096338A1 (en) 2005-03-04 2006-02-24 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents

Publications (1)

Publication Number Publication Date
MX2007010099A true MX2007010099A (es) 2007-10-12

Family

ID=36676308

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007010099A MX2007010099A (es) 2005-03-04 2006-02-24 Las 1,3-tiazol-5-carboxamidas utiles como agentes quimioterapeuticos contra el cancer.

Country Status (15)

Country Link
US (1) US20090023753A1 (es)
EP (1) EP1858893A1 (es)
JP (1) JP2008531688A (es)
KR (1) KR20070118100A (es)
CN (1) CN101133054A (es)
AU (1) AU2006221037A1 (es)
BR (1) BRPI0609147A2 (es)
CA (1) CA2600039A1 (es)
CR (1) CR9340A (es)
EA (1) EA200701881A1 (es)
IL (1) IL185518A0 (es)
MA (1) MA29671B1 (es)
MX (1) MX2007010099A (es)
TN (1) TNSN07300A1 (es)
WO (1) WO2006096338A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207781B1 (en) 2007-09-24 2012-11-28 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
KR101051078B1 (ko) 2008-12-05 2011-07-21 한국화학연구원 염증관련 질환치료제용 2,4-이중치환-5-아미노카르보닐-1,3-티아졸 유도체, 그의 제조방법 및 그를 유효성분으로 함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련질환 치료제
WO2012036974A1 (en) * 2010-09-14 2012-03-22 Schering Corporation Novel thiazol-carboximide derivatives as pdk1 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995162B2 (en) * 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
TWI299664B (en) * 2003-01-06 2008-08-11 Osi Pharm Inc (2-carboxamido)(3-amino)thiophene compounds
DE102004039876A1 (de) * 2004-06-23 2006-01-26 Lanxess Deutschland Gmbh Herstellung von fluorierten 1,3-Benzodioxanen

Also Published As

Publication number Publication date
JP2008531688A (ja) 2008-08-14
WO2006096338A1 (en) 2006-09-14
US20090023753A1 (en) 2009-01-22
TNSN07300A1 (en) 2008-12-31
EA200701881A1 (ru) 2008-02-28
CN101133054A (zh) 2008-02-27
EP1858893A1 (en) 2007-11-28
BRPI0609147A2 (pt) 2010-02-17
CA2600039A1 (en) 2006-09-14
KR20070118100A (ko) 2007-12-13
AU2006221037A1 (en) 2006-09-14
MA29671B1 (fr) 2008-08-01
CR9340A (es) 2010-04-05
IL185518A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
SI1853602T1 (sl) Kemične spojine
PL1853588T3 (pl) Związki chemiczne
TW200801003A (en) Novel compounds
TW200508214A (en) Novel compounds
DE602004021472D1 (en) Pyrimiidinverbindungen
TW200718422A (en) 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
TW200833670A (en) Novel compounds 569
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
JO2578B1 (en) Compounds Theophene benzimidazole
TW200738659A (en) Novel compounds
SG158091A1 (en) Imidazoazepinone compounds
TW200604197A (en) New compounds
TW200745122A (en) New compounds I
MY141233A (en) Enantiomers of selected fused heterocyclics and uses thereof
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
TW200740781A (en) Novel compounds
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
DE60201074D1 (en) Pyrazolopyridinderivate
TNSN07300A1 (en) 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents
MX2007001954A (es) Heterociclicos fusionados seleccionados y sus usos.
TW200720262A (en) Novel compounds ii
TW200745133A (en) New compounds II

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT